Review article: potassium-competitive acid blockers for the treatment of acid-related disorders.
Yousef Abdel-AzizDavid C MetzColin W HowdenPublished in: Alimentary pharmacology & therapeutics (2021)
P-CABs have some potential advantages over PPIs. To date, most research has been conducted in Asia; results of clinical trials that are underway in the United States and Europe are anticipated in 2021.